Empress Emeritus Low recurrence risk to treatment with medication in the future September 20 18:51
As a result of pathological diagnosis, Empress Empress, who underwent breast cancer removal surgery on the 8th of this month, was judged to have a very low risk of recurrence, and now she can receive hormonal therapy by taking drugs.
Empress Emeritus was admitted to the University of Tokyo on the 7th of this month and was operated on the next 8th to remove early breast cancer and its surroundings.
According to the Imperial Household Agency, the progress after surgery was smooth, and as a result of pathological diagnosis examining the excised tissue in detail, the cancer was completely removed, the stage was 1, and the risk of recurrence was judged to be very low.
In the future, Empress will be able to undergo tests to check for recurrence once every three months to half a year while receiving hormone therapy that takes drugs that suppress the growth of cancer cells.
According to the Imperial Household Agency, in the morning of the 20th, doctors explained the results of the diagnosis to the Emperor and his wife, and it seemed that they were somewhat relieved.
According to the Imperial Household Agency, “I want to watch over the situation carefully while creating an environment where people can live peacefully, so that mental burdens will not be applied, as examinations and treatments continue.”